Ju Lee

Ju Lee serves as a Clinical Instructor of Medicine at the University of Southern California, actively contributing to research in liver transplantation, hepatocellular carcinoma, and pediatric liver diseases. Her work addresses critical challenges including geographic disparities in organ allocation, financial toxicity in living donor transplantation, and racial inequities in access to care for hepatitis C-associated hepatocellular carcinoma.

Research interests encompass transplant immunology, surgical oncology, and health services research. Dr. Lee investigates immune mechanisms in rejection using spatial proteomics (notably the IMmuneCite workflow), develops predictive tools like the CHALF score for pediatric acute liver failure, and examines systemic issues such as authorship equity in academic surgery. Her interdisciplinary approach bridges clinical practice with translational science, focusing on normothermic machine perfusion, multi-organ allocation strategies, and same-day discharge protocols.

Analysis of recent publications (2024-2025) reveals a dominant focus on liver transplantation, with emerging themes in immune exhaustion biomarkers, financial barriers for living donors, and racial disparities in transplant access. The work increasingly integrates multi-omics data to dissect alloimmune microenvironments, while consensus conference contributions highlight leadership in shaping clinical guidelines through organizations like the International Liver Transplantation Society.

No scientific awards were mentioned in the available information.

While specific student mentorship details are absent, Dr. Lee's collaborative research involves multi-institutional teams and societies such as ILTS. Grant funding sources aren't specified, but her high publication volume suggests active research support. Her methodological expertise in spatial proteomics and multi-omics analysis positions her at the forefront of translational transplant science.

Dr. Lee participates in consensus-building initiatives for highly sensitized transplant candidates and psychosocial evaluation protocols, demonstrating commitment to improving systemic aspects of transplantation medicine beyond individual patient care.